GlassScriptPhysician profile
Ben Pascario
NPI 1174629471
$2,364.24
in general payments reported to CMS, 2019-2025
23 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $315 · 2021: $318 · 2022: $454 · 2023: $146 · 2024: $171 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $501.96 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $350.61 | 2020-2025 | Xtampza |
| Exact Sciences Corporation | $275.72 | 2023-2025 | Cologuard Collection Kit |
| Lupin INC. | $173.12 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $167.33 | 2022 | |
| Scynexis, INC. | $160.31 | 2022 | |
| Exeltis, USA INC. | $154.09 | 2019 | |
| Therapeuticsmd, INC. | $127.63 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $65.37 | 2021-2022 | |
| Almatica Pharma LLC | $49.25 | 2021-2022 | |
| Evofem Biosciences, INC. | $46.03 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $44.45 | 2025 | |
| Millicent US INC | $43.75 | 2020 | |
| Duchesnay USA Incorporated | $31.54 | 2019 | |
| Amgen INC. | $25.57 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $23.27 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.79 | 2021 | |
| Hologic Sales and Service, LLC | $20.27 | 2024 | Aptima |
| Celularity INC. | $19.00 | 2019 | |
| Astellas Pharma US INC | $17.96 | 2023 | Veozah |
| Myovant Sciences INC. | $17.28 | 2021 | |
| Pfizer INC. | $16.78 | 2023 | |
| Allergan, INC. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Pascario listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.